KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Current Assets (2018 - 2025)

Historic Current Assets for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to $357.6 million.

  • Castle Biosciences' Current Assets rose 371.17% to $357.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $357.6 million, marking a year-over-year increase of 371.17%. This contributed to the annual value of $360.2 million for FY2024, which is 2182.39% up from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Current Assets is $357.6 million, which was up 371.17% from $348.7 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Current Assets ranged from a high of $426.7 million in Q1 2021 and a low of $269.1 million during Q2 2023
  • Over the past 5 years, Castle Biosciences' median Current Assets value was $336.4 million (recorded in 2022), while the average stood at $330.9 million.
  • Per our database at Business Quant, Castle Biosciences' Current Assets skyrocketed by 26607.69% in 2021 and then plummeted by 2314.52% in 2022.
  • Over the past 5 years, Castle Biosciences' Current Assets (Quarter) stood at $353.7 million in 2021, then fell by 17.37% to $292.3 million in 2022, then increased by 1.15% to $295.6 million in 2023, then rose by 21.82% to $360.2 million in 2024, then decreased by 0.72% to $357.6 million in 2025.
  • Its Current Assets was $357.6 million in Q3 2025, compared to $348.7 million in Q2 2025 and $349.4 million in Q1 2025.